3 END MODIFIED OLIGODEOXYNUCLEOTIDES PHOSPHOROTHIOATE - PHARMACOKINETICS AND STABILITY IN MICE

被引：0
|
作者：
TEMSAMANI, J [1 ]
TANG, JY [1 ]
PADMAPRIYA, A [1 ]
KUBERT, M [1 ]
AGRAWAL, S [1 ]
机构：
[1] HYBRIDON INC, WORCESTER, MA 01605 USA
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1993年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and stability of phosphodiester and phosphorothioate 3′ end modified oligonucleotides in the blood in vivo:: A comparative study
    Laktionov, PP
    Bryksin, AV
    Rykova, EY
    Amirchanov, NV
    Vlassov, VV
    VOPROSY MEDITSINSKOI KHIMII, 1999, 45 (03): : 206 - 215
  • [2] ANALYSIS AND EXPLORATORY PHARMACOKINETICS OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES
    BIGELOW, JC
    CHRIN, LR
    MATHEWS, LA
    MCCORMACK, JJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (01) : 134 - 134
  • [3] UPTAKE MECHANISMS AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE MODIFIED OLIGODEOXYNUCLEOTIDES
    BELTINGER, CP
    SMITH, RM
    SARGOVI, HU
    GEWIRTZ, AM
    BLOOD, 1993, 82 (10) : A117 - A117
  • [4] BINDING, UPTAKE, AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE-MODIFIED OLIGODEOXYNUCLEOTIDES
    BELTINGER, C
    SARAGOVI, HU
    SMITH, RM
    LESAUTEUR, L
    SHAH, N
    DEDIONISIO, L
    CHRISTENSEN, L
    RAIBLE, A
    JARETT, L
    GEWIRTZ, AM
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04): : 1814 - 1823
  • [5] Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice
    Rifai, A
    Brysch, W
    Fadden, K
    Clark, J
    Schlingensiepen, KH
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (02): : 717 - 725
  • [6] End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides
    Hebb, MO
    Robertson, HA
    MOLECULAR BRAIN RESEARCH, 1997, 47 (1-2): : 223 - 228
  • [7] SYNTHESIS OF BASE MODIFIED PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES AS INHIBITORS OF HIV-1
    KEMAL, O
    BROWN, T
    BURGESS, S
    BISHOP, JD
    LEIGHBROWN, AJ
    NUCLEOSIDES & NUCLEOTIDES, 1991, 10 (1-3): : 555 - 561
  • [8] PHARMACOKINETICS, TISSUE DISTRIBUTION, AND STABILITY OF ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE ISIS-3466 IN MICE
    SAIJO, Y
    PERLAKY, L
    WANG, HM
    BUSCH, H
    ONCOLOGY RESEARCH, 1994, 6 (06) : 243 - 249
  • [9] THE STABILITY, TOXICITY AND EFFECTIVENESS OF UNMODIFIED AND PHOSPHOROTHIOATE ANTISENSE OLIGODEOXYNUCLEOTIDES IN XENOPUS OOCYTES AND EMBRYOS
    WOOLF, TM
    JENNINGS, CGB
    REBAGLIATI, M
    MELTON, DA
    NUCLEIC ACIDS RESEARCH, 1990, 18 (07) : 1763 - 1769
  • [10] Accessible 5′-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity
    Yu, D
    Zhao, Q
    Kandimalla, ER
    Agrawal, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (23) : 2585 - 2588
12345